JP Morgan Maintains Underweight on Agilon Health, Raises Price Target to $85
JP Morgan analyst Lisa Gill maintains Agilon Health (NYSE:AGL) with a Underweight and raises the price target from $31 to $85.
Read original at benzingaStocks · News reference
Top Wall Street analysts changed outlook on top names. See all rating changes on our analyst ratings page. ROL downgraded and price target cut.
Reference details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
JP Morgan analyst Lisa Gill maintains Agilon Health (NYSE:AGL) with a Underweight and raises the price target from $31 to $85.
Read original at benzingaWells Fargo analyst Stephen Baxter maintains Agilon Health (NYSE:AGL) with a Overweight and raises the price target from $141 to $146.
Read original at benzingaTop Wall Street analysts upgraded various stocks, including BBY, BCE. See what other analysts think.
Read original at benzingaCitigroup analyst Daniel Grosslight upgrades Agilon Health (NYSE:AGL) from Sell to Neutral and raises the price target from $105 to $115.
Read original at benzingaNew responsible AI features bring enhanced transparency and governance to AI-powered marketing, while a new partnership with Gryphon unites responsible AI with compliance assurancePegasystems Inc. (NASDAQ:PEGA), the
Read original at benzinga